Sleep And Breathing Health — Operating Income (Loss)
ResMed Sleep And Breathing Health — Operating Income (Loss) increased by 0.6% to $575.41M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.3%, from $494.80M to $575.41M. Over 2 years (FY 2023 to FY 2025), Sleep And Breathing Health — Operating Income (Loss) shows an upward trend with a 16.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong segment performance and operational efficiency, while a decrease signals margin compression or declining demand.
Detailed definition
Measures the profitability of the Sleep and Breathing Health segment after deducting direct and indirect operating expen...
Peer comparison
Standard segment operating income metric used by diversified companies to report divisional performance.
rmd_segment_sleep_and_breathing_health_operating_income_lossHistorical Data
| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $361.78M | $361.78M | $361.78M | $361.78M | $374.74M | $409.14M | $456.18M | $441.29M | $460.98M | $488.72M | $494.80M | $519.89M | $530.62M | $571.85M | $575.41M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.6% | +9.2% | +11.5% | -3.3% | +4.5% | +6.0% | +1.2% | +5.1% | +2.1% | +7.8% | +0.6% |
| YoY Change | — | — | — | — | +3.6% | +13.1% | +26.1% | +22.0% | +23.0% | +19.5% | +8.5% | +17.8% | +15.1% | +17.0% | +16.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is ResMed's sleep and breathing health — operating income (loss)?
- ResMed (RMD) reported sleep and breathing health — operating income (loss) of $575.41M in Q1 2026.
- How has ResMed's sleep and breathing health — operating income (loss) changed year-over-year?
- ResMed's sleep and breathing health — operating income (loss) increased by 16.3% year-over-year, from $494.80M to $575.41M.
- What is the long-term trend for ResMed's sleep and breathing health — operating income (loss)?
- Over 2 years (2023 to 2025), ResMed's sleep and breathing health — operating income (loss) has grown at a 16.5% compound annual growth rate (CAGR), from $1.45B to $1.96B.
- What does sleep and breathing health — operating income (loss) mean?
- The profit or loss generated by the Sleep and Breathing Health segment from its core business activities.